Skip to main content

Syensqo

MaterialsBrussels, BelgiumFounded 2023· One of 1019 Materials companies tracked by AMPulse

A global science company developing advanced materials and specialty chemicals that enhance quality of life through innovative solutions across aerospace, automotive, electronics, healthcare, and consumer markets.

CEO / Founder
Mike Radossich
Team Size
10000+
Stage
Public
Total Funding
Publicly Traded
Latest Round
IPO
Key Investors
BlackRock (4.17% stake), The Capital Group Companies Inc. (crossed 5% voting-rights threshold, Aug 2026), Institutional Investors, Public Market Investors

Technology & Products

Key Products

Specialty polymers, composite materials, specialty formulations, advanced materials, and high-value formulations for industries including aerospace, automotive, electronics, healthcare, and consumer markets.

Technological Advantage

Integrated innovation ecosystem spanning specialty polymers, composite materials, fluorochemistry, and biosolutions; strong R&D capabilities with 2,000+ scientists and engineers; active IP portfolio management protecting proprietary technologies; focus on sustainable solutions through renewable materials, circular chemistry, and biotechnology acquisitions.

Patent position

Syensqo filed 11 patent families in 2022–2024, falling 76% from 46 in 2019–2021, while tracked AM filings in the same patent offices fell 17%. Material extrusion’s share rose from 35% to 100%. AMPulse analysis

Filing momentum
11 families filed 2022–2024, 46 in 2019–2021 (-76%); all tracked AM filings in the same offices -17%
Process mix, 2019–2021 → 2022–2024
Material extrusion 35% → 100%
Focus, 2019–2021 → 2022–2024
Materials 86% → 100%
Filed in
EP 29%US 28%WO 25%CN 24%
Named competitors, AM patent families
Victrex 17Arkema 132

120 AM patent families in total. Recent years are still being published, so read a filing change against the same-office figure.

Differentiation

Value Proposition

Provides the industry's broadest portfolio of specialty polymers and advanced materials enabling customers to develop safer, cleaner, and more sustainable products with superior performance in extreme environments, while transitioning to renewable and circular solutions.

How They Differentiate

Industry's broadest specialty polymer portfolio with 50+ years of materials science heritage; leverages AI-driven research through SyGPT for accelerated material discovery; integrated innovation ecosystem spanning specialty polymers, composite materials, fluorochemistry, and biosolutions with strong focus on sustainable and circular technologies

Market & Competition

Target Customers

Original equipment manufacturers (OEMs) and industrial companies across aerospace, automotive, electronics, healthcare, consumer goods, agriculture, and energy sectors seeking high-performance materials and specialty chemicals

Industry Verticals

Aerospace & Defense, Automotive & Transportation, Electronics & Semiconductors, Healthcare & Medical Devices, Consumer Goods & Packaging, Agriculture & Food, Energy & Clean Technology, Industrial Manufacturing

Competitors

Victrex, Arkema, Kureha Corporation

Growth & Milestones

Growth Metrics

€6.85B revenue (2024); 21.5% EBITDA margin; 82% cash conversion; €390M free cash flow to shareholders (2024); 13,000+ employees across 30 countries

Major Milestones

Successfully completed spin-off from Solvay SA on December 11, 2023, Trading began on Euronext Brussels and Paris with €9.5B market capitalization, Joined BEL20 index shortly after public listing, 2024 first full year as independent company achieving €6.85B revenue, Announced €300M share buyback program in Q4 2024, Mike Radossich assumed CEO role in January 2026, Launched SyGPT AI chatbot in partnership with Microsoft Azure, Partnered in Climate Impulse project for green hydrogen aircraft (2024), Completed divestiture of Oil & Gas Business Unit (oilfield stimulation chemicals, ~€400M 2024 net sales, ~600 employees) to SNF Group for €135M enterprise value, effective January 2, 2026

Notable Customers

Boeing, Airbus, COMAC

https://www.syensqo.com

Recent coverage of Syensqo

AM patents

AM-relevant patents linked to this company.

Patents
130
Granted
28
Families
120

Leading domains: process (130), material (80), equipment (20)

Filings by year: 2024: 1 · 2023: 1 · 2022: 9 · 2021: 8 · 2020: 20 · 2019: 22

  1. METHOD FOR MANUFACTURING A THREE-DIMENSIONAL OBJECT3436503 · EP
  2. Process for preparing polyphenylene sulfide polymer particles110741032 · CN
  3. POLYAMIDES OBTAINABLE FROM 3-(AMINOALKYL)BENZOIC ACID03638713 · EP
  4. PEEK-PEoEK COPOLYMER POWDER AND METHOD OF PREPARING THE POWDER2021001132 · WO
  5. FILAMENT CONTAINING POLYAMIDE (PA) POLYMER AND ITS USE FOR ADDITIVE MANUFACTURING04499730 · EP

Funding rounds

  • Spin-off/IPO€9.5B (Market Cap)2023-12Lead: Public Listing · Source: Solvay press release, Euronext

Why this company matters

AMPulse analysis, not a company disclosure

Syensqo emerged in December 2023 as a pure-play specialty materials company following its spin-off from Solvay, inheriting more than 50 years of polymer science heritage. The Brussels-based firm positions itself as a top-three global leader in high-performance polymers, particularly PEEK, where it controls over 80% of worldwide production capacity alongside Victrex and Evonik.

The company's core offering spans specialty polymers, composite materials, fluorochemistry, and biosolutions, targeting extreme-environment applications in aerospace, automotive, electronics, and healthcare. Syensqo supplies OEMs such as Boeing, Airbus, and COMAC with materials designed for thermal, chemical, and mechanical stress. Its technology stack includes AI-driven material discovery through SyGPT, a chatbot developed in partnership with Microsoft Azure, and an integrated innovation network staffed by over 2,000 scientists and engineers.

Syensqo's strategic moat rests on its unmatched breadth of specialty polymer grades and its ability to co-develop formulations with customers across regulated industries. The company reported €6.85 billion in revenue for 2024, its first full year as an independent entity, with a 21.5% EBITDA margin and €390 million in free cash flow. A €300 million share buyback program announced in late 2024 signals confidence in its capital allocation model.

Competitive risks include pricing pressure from Arkema, Kureha, and Chinese entrant Anmate Technology, as well as the challenge of maintaining premium positioning while scaling circular and bio-based material lines. Syensqo's acquisitions in synthetic biology, including a Boston R&D center from Ginkgo Bioworks, and its involvement in the Climate Impulse green hydrogen aircraft project indicate a long-term bet on sustainable aviation and renewable chemistry.